On a collision course: SARS-CoV-2 variants and CAR T cells

Blood Adv. 2023 Jun 13;7(11):2643-2644. doi: 10.1182/bloodadvances.2023010371.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Immunotherapy, Adoptive
  • SARS-CoV-2*
  • T-Lymphocytes
  • Vaccination

Substances

  • Antibodies, Monoclonal
  • COVID-19 Vaccines

Supplementary concepts

  • SARS-CoV-2 variants